XML 21 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
 3 Months Ended 12 Months Ended
Mar. 31, 2012
Mar. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (17,396,538) $ (18,285,609)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock compensation expense 188,509 275,003
Stock issued in connection with in-licensing agreement 16,578,000 16,875,000
Changes in assets and liabilities, net of effects of acquisition:    
Decrease in other current assets 8,147 11,740
Increase in accounts payable and accrued expenses (254,604) 153,706
Increase in interest payable 14,852 21,949
Net cash used in operating activities (861,634) (948,211)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Cash acquired in connection with acquisition 0 10,386
Net cash provided by investing activities 0 10,386
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments of short-term loans (200,000) (200,000)
Proceeds from sale of common stock, net 0 9,824,682
Proceeds from sale of preferred stock, net 12,257,309 12,257,309
Offering costs paid (20,416) (20,416)
Net cash provided by financing activities 12,036,893 21,861,575
NET INCREASE IN CASH AND CASH EQUIVALENTS 11,175,259 20,923,750
Cash and cash equivalents at beginning of period 9,748,491 0
CASH AND CASH EQUIVALENTS AT END OF PERIOD 20,923,750 20,923,750
NON-CASH TRANSACTIONS:    
Conversion of notes payable to preferred stock 0 55,271
Accrued financing costs $ 55,487 $ 116,626